垂体ACTH瘤病理评估研究进展
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R736.4

基金项目:

江苏省卫生健康委员会医学科研重点项目 (K2023046)


Advances in pathological evaluation of ACTH⁃secreting pituitary adenomas
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    分泌促肾上腺皮质激素(adrenocorticotropic hormone,ACTH)的垂体腺瘤(垂体ACTH瘤)因过度分泌ACTH刺激双侧肾上腺皮质增生而引起高皮质醇血症,也称作库欣病(Cushing’s disease,CD),是内源性高皮质醇血症最常见的原因。垂体 ACTH瘤可导致电解质紊乱,糖、脂代谢紊乱等一系列严重的临床症候群,累及全身多个脏器及系统。经蝶窦神经内镜手术是垂体ACTH瘤的一线治疗方法,可以得到较高的缓解率,但术后复发和持续状态仍然是垂体ACTH瘤治疗的一个未解决的问题。垂体ACTH瘤病理评估在确定病变性质、预测其预后及药物治疗选择方面均有重要的价值。文章就垂体ACTH瘤病理评估的相关进展进行综述,包括新的免疫组化标志物和镜下特殊表现。

    Abstract:

    Pituitary adenomas secreting adrenocorticotropin hormone(ACTH),known as ACTH-secreting pituitary adenomas,cause hypercortisolism by overproducting ACTH and stimulating bilateral adrenal cortical hyperplasia,a condition also known as Cushing’s disease(CD),which is the most common cause of endogenous hypercortisolism. ACTH-secreting pituitary adenomas lead to a series of severe clinical syndromes,including electrolyte disturbances and disorders of glucose and lipid metabolism,affecting multiple organs and systems throughout the body. Transsphenoidal neuroendoscopic surgery is the first -line treatment for ACTH-secreting pituitary adenomas,with a high remission rate,but postoperative recurrence and persistent disease remain unsolved in the treatment of ACTH-secreting pituitary adenomas. The pathological evaluation of ACTH-secreting pituitary adenomas has important value in determining the nature of the lesions,predicting the prognosis,and selecting the drug therapy. This article reviews the advances in the pathologic evaluation of ACTH-secreting pituitary adenomas,including new immunohistochemical markers and microscopic special features.

    参考文献
    相似文献
    引证文献
引用本文

计铭钰,杨宇宏,孙敏.垂体ACTH瘤病理评估研究进展[J].南京医科大学学报(自然科学版),2024,(5):732-737

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-12-27
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-15
  • 出版日期:
通知关闭
郑重声明